Chronic

On-line Webcast Discusses Chronic Lymphocytic Leukemia

by

OSUWexnerbloglogo2014 On-line Webcast Discusses Chronic Lymphocytic Leukemia. On this CME webcast, we’re going to bring you up to date on the latest about chronic lymphocytic leukemia, or CLL. Joining us is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Kerry Rogers. And also hematologist and Associate Professor of Internal Medicine from OSU and the James Cancer Hospital, Dr. Jennifer Woyach.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CLL is a chronic lymphoid malignancy which does not need treatment at diagnosis if asymptomatic and has a survival of many years; CLL patients are at higher risk for second cancers or infection so it is important so all CLL patients with CLL should get all age appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait approach; and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL.

You’ll also learn about the following:

  • Risks for CLL
  • Current approach to treatment of CLL
  • Roles and limitations of automated WBC differentials
  • Initial approach to lymphocytosis
  • Emerging trends in first line treatment of CLL
  • Role of age of the patient in therapeutic decision making
  • Stem cell transplants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Depression in the Setting of Chronic Medical Conditions

by

OSUWexnerbloglogo2014 Learn About Depression in the Setting of Chronic Medical Conditions. More choices in depression management means more decisions to make in depression management. And more decisions can create a conundrum for physicians. On this CME webcast, we are going to help you navigate the often confusing challenge of treating depression in patients with medical illness. Joining us today is Assistant Professor of Psychiatry, Dr. Kevin Johns.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTANDING how depression impacts other medical conditions; and UNDERSTANDING how to diagnose and treat depression in patients with chronic medical problems.

You’ll also learn about the following:

  • Depression in medical illness
  • Whether the choice of anti-depressant matters

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Education Discusses Lymphoma

by

OSUWexnerbloglogo2014 On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.

You’ll also learn about the following:

  • What causes lymphoma
  • The spectrum of lymphomas
  • Stem cell transplant in aggressive lymphomas
  • Whether there a role for “maintenance rituximab”
  • Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
  • Lymphoma mimics
  • Deciding when to biopsy an enlarged lymph node

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Approach to Cough on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Approach to Cough on CME Webcast. A chronic cough can affect a patient’s quality of life and can be frightening to patients who are worried that it could be a symptom of a life-threatening disease. Joining our moderator in the studio to tell us about the causes and clinical approach to acute and chronic cough are two pulmonologists from the Ohio State University. We have Dr. Vincent Esguerra who is an Assistant Professor of Internal Medicine and Dr. Carleen Risaliti who is also an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of chronic cough and recognize associated signs/symptoms; APPLY an appropriate diagnostic and treatment algorithm to patients with chronic cough; DESCRIBE the general mechanism of the cough reflex; and UNDERSTAND the distinction between acute, sub-acute, and chronic cough.

You’ll also learn about the following:

  • Role of the chest x-ray in evaluation of cough
  • Opioid cough suppressants
  • Cough suppression therapies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Discover Device Therapies for Heart Failure on Webcast

by

OSUWexnerbloglogo2014 Discover Device Therapies for Heart Failure on Webcast. In the past, we could prescribe medications or do a heart transplant, but that was about it. Now we have new devices that can help our patients with heart failure. On this CME webcast, we’re going to hear about these new devices to show you how these treatments can help them live longer and better lives. Joining our moderator in the studio are cardiologists and heart failure experts from the Ohio State University. Dr. Rami Kahwash is an Associate Professor of Internal Medicine and he is the Director of the Cardiovascular Research Organization at OSU. And Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the primary prevention strategies of the prevention of sudden cardiac death in chronic systolic heart failure and the role of Cardiac Resynchronization therapy (CRT); and UNDERSTAND indications of the new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • Medications versus implantable cardiac defibrillators
  • Implantable cardiac monitoring devices
  • Precautions when caring for patients with a ventricular assist device
  • Complications of ventricular assist devices
  • Investigational devices
  • Current role of the intra-aortic balloon pump

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.